Navigation Links
PSA-testing and early treatment decreases risk of prostate cancer death
Date:3/10/2014

Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from Ume University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY, USA.

The study is based on data from nation-wide, population-based registers in Sweden including the Cancer Register, The Cause of Death Register and the National Prostate Cancer Register (NPCR) of Sweden.

"Our results show that prostate cancer mortality was 20 procent lower in counties with the highest incidence of prostate cancer, indicating an early and rapid uptake of PSA testing, compared with counties with a slow and late increase in PSA testing," says Pr Stattin, lead investigator of the study.

"Since the difference in the number of men diagnosed with prostate cancer is related to how many men undergo PSA testing, we think our data shows that PSA testing and early treatment is related to a modest decrease in risk of prostate cancer death," says Hkan Jonsson statistician and senior author of the study.

"In contrast to screening in randomized studies our data is based on unorganized, real life PSA testing. We therefore used a statistical method that excludes men that were diagnosed prior to the introduction of PSA testing since these men could not benefit from the effect of PSA testing," continues Hkan Jonsson.

"The results in our study are very similar to those obtained in a large European randomized clinical study (ERSPC) thus confirming the effect of PSA testing on the risk of prostate cancer death. However, we have to bear in mind that the decrease in mortality is offset by overtreatment and side effects from early treatment. PSA testing sharply increases the risk of overtreatment, i.e. early treatment of cancers that would never have surfaced clinically. We also know that after surgery for prostate cancer most men have decreased erectile function and that a small group of men suffer from urinary incontinence. Our data pinpoints the need for refined methods for PSA testing and improved prostate cancer treatment strategies," concludes Dr. Stattin.


'/>"/>

Contact: Pär Stattin
par.stattin@umu.se
46-736-205-251
Umea University
Source:Eurekalert  

Related medicine news :

1. New Stool Test Might Aid in Early Detection of Colon Cancer
2. An Early Start for Your Child with Autism
3. Early Study Finds Some Promise for Lung Cancer Vaccine
4. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
5. JCI early table of contents for April 9, 2012
6. Eye Tremors May Aid Early Diagnosis of Parkinsons: Study
7. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
8. First contact: Early intervention key in diagnosis and treatment of serious mental illness
9. Brain Tumor Vaccine Shows Promise in Early Trial
10. Role of Screening, Monitoring in Early Kidney Disease Unclear
11. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PSA-testing and early treatment decreases risk of prostate cancer death
(Date:7/20/2017)... ... 2017 , ... A July 7th article on ... veins in some patients, according to medical experts. Washington State medical clinic Northwest ... sitting or standing, or regularly nicking yourself while shaving your legs, and taking ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the New Final ... to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. – 3:00 ... for Clinical Trials Registration and Results Information,” is a head-scratcher. After reading and ...
(Date:7/18/2017)... Bradley, Illinois (PRWEB) , ... July 18, 2017 , ... ... Luau Luncheon from 11 a.m. to 12:30 p.m. on Aug. 15. , The community, ... all incomes, including those on Medicaid, who need some help to maintain their independence. ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... McGraw Family ... Patient Care and Train Next Generation of Healthcare Clinicians , NORWALK, Connecticut – ... is continuing its legacy of investing in community health by pledging up to $3 ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... ... education recruitment firm, recently completed a nationwide executive search for Springfield Clinic’s Chief ... Springfield Clinic named Ray Williams, a skilled healthcare executive with more than 30 ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
(Date:7/10/2017)...  BDI Group subsidiary Pathway Purchasing Network, a ... serving specialty pharmacies, home infusion companies and physician ... value-added member programs designed to help organizations gain ... improve access and affordability for patients who rely ... Pathway has worked with ...
(Date:7/6/2017)... -- ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is celebrating ... support. To celebrate its anniversary, ThriveRx recently launched a redesigned ... look with improved organization to create the best user experience for consumers ... ... "We,ve made several great strides throughout ...
Breaking Medicine Technology: